INDVINDIVIOR PLC

Nasdaq www.indivior.com/en


$ 9.55 $ -0.36 (-3.64 %)    

Monday, 16-Sep-2024 15:59:55 EDT
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 9.54
$ 9.89
$ 9.55 x 200
$ 9.56 x 300
$ 9.52 - $ 9.89
$ 9.14 - $ 23.22
338,599
na
1.3B
$ 1.82
$ 651.23
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 piper-sandler-reiterates-overweight-on-indivior-maintains-22-price-target

Piper Sandler analyst David Amsellem reiterates Indivior (NASDAQ:INDV) with a Overweight and maintains $22 price target.

 indivior-shares-update-on-aelis-farmas-phase-2b-study-with-aef0117-in-participants-with-cannabis-use-disorder

Primary and Secondary End Points of the Study were Not Met Indivior Does Not Currently Expect to Exercise AEF0117 Option 

 johnson-johnson-partner-addex-therapeutics-selects-investigational-compound-for-substance-use-disorder

Addex Therapeutics stock surged after announcing clinical candidate selection with Indivior for substance use disorder treatmen...

 indivior-announces-bardas-first-order-of-opvee-nasal-spray-to-combat-opioids-and-aid-in-national-preparedness-barda-will-use-87m-in-project-bioshield-designated-funding-for-the-initial-procurement

BARDA purchased OPVEE, a nalmefene opioid overdose reversal nasal sprayThrough BARDA's contract with Indivior, communities ...

 indivior-expects-2024-net-revenue-of-115b-1215b-vs-consensus-of-1215b-adjusted-gross-margin-of-low-mid-80-range-adjusted-operating-income-of-285m-320m

FY    2024    Guidance On    July    9th,    the    Group    updated    its  

 indivior-announces-accelerated-100m-share-repurchase-program-targeting-completion-within-six-months

Repurchases Under Current Program now Expected to be Completed by End of July RICHMOND, Va., July 25, 2024 /PRNewswire/ -- ...

 indivior-q2-eps-044-beats-014-estimate-sales-29900m-beat-29605m-estimate

Indivior (NASDAQ:INDV) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.14 by 214...

 piper-sandler-initiates-coverage-on-indivior-with-overweight-rating-announces-price-target-of-22

Piper Sandler analyst David Amsellem initiates coverage on Indivior (NASDAQ:INDV) with a Overweight rating and announces Pri...

 craig-hallum-maintains-buy-on-indivior-lowers-price-target-to-24

Craig-Hallum analyst Chase Knickerbocker maintains Indivior (NASDAQ:INDV) with a Buy and lowers the price target from $37 to...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION